RAD51C and ovarian carcinoma: For example, p.Gly264Ser has previously been reported in several small studies to be associated with ovarian cancer and/or BC4–6, which was consistent with functional assays showing this variant caused the partial reduction of RAD51C cellular function including cell survival, mitomycin C sensitivity and homologous recombination activity5,9.